Connect with us

Hi, what are you looking for?

Jewish Business News


Three Way Takeover Battle: Statistics weigh against Teva’s Mylan bid succeeding

A Credit Suisse study finds that most hostile bids fail, especially if antitrust concerns are involved.

L-R Joseph Papa,   Perrigo,   Robert,   Coury-1-Mylan,   Erez Vigodman,   Teva


Will drug company Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) succeed in its attempted hostile takeover of rival Mylan (MYL), or will it be Mylan that succeeds in its own hostile takeover bid for Perrigo (PRGO)? If the statistics are anything to go by, the chances are that both attempts will fail.

A study by Credit Suisse indicates that, since 1995, only 38% of hostile takeover bids have proved successful. According to the study, the size of the deal makes no difference to the chances of success, but it does point out that no hostile takeover bid over $10 billion has been successfully completed since Amgen acquired biotechnology company Onyx two years ago.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

Mylan is attempting to take over Perrigo in a deal that would be worth over $34 billion. Perrigo’s board opposes the bid, but Mylan plans to convene a shareholders’ meeting to approve it early in the third quarter. At the same time, Teva seeks to take over Mylan in an even larger deal, of over $40 billion, and Mylan’s board opposes this adamantly. Completion of the Teva-Mylan deal is conditional on the Mylan-Perrigo deal not going ahead…


GLOBES logo-eng (1)Published by Globes [online], Israel business news –




Search Results for: Mylan

L-R Robert-J-Coury-1-Mylan- Teva Erez Vinograd and Yitzhak Peterburg

By Clive Minchom On Monday, June 8th, 2015

Teva Issues New Letter to Mylan NV Confirming Seriousness of Offer to Acquire Mylan

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) issued a new open letter on Monday, signed by both the Teva Chairman Yitzhak Peterburgand and Teva’s CEO Erez Vigodman, addressed to Robert More…

TEVA ,   EREZ VIGODMAN Robert-J-Coury-1 Mylan 320X=p

By Ilan Shavit On Tuesday, June 2nd, 2015

Mylan to Teva: Stop Playing Games With Our Company

Mylan reports that Teva Pharmaceutical Industries, which has made an unsolicited offer for the company, violated U.S. anti-trust rules by acquiring a stake, but did not clarify which anti-trust rule it violated. Five More…

L- R Joseph Papa,   Perrigo,   Heather Bresch of Maylen ,   Erez Vigodman ,  Teva  - 11

By Niva Goldberg On Saturday, May 30th, 2015

Mylan’s CEO on Teva “They Are Getting Ready to Go Off the Cliff”

“We just don’t think Teva is the right company” to combine with, “They are getting ready to go off the cliff, ” Mylan NV, CEO Heather Bresch said Friday at a conference in New York City hosted by Sanford More…

Joseph C. Papa - PERRIGO - PR

By Niva Goldberg On Tuesday, May 19th, 2015

Perrigo CEO Will Discuss Deal With Mylan at Right Price

Perrigo Company (NYSE:PRGO; TASE:PRGO) CEO Joseph Papa is ready to talk with Mylan N.V. (MYL) about its takeover bid, but at a higher price. The rival drugmaker’s present bid is nowhere near there. Perrigo More…

Teva CFO Eyal-Desheh

By Shiri Habib-Valdhorn On Thursday, May 14th, 2015

Three Way Takeover Battle- Teva: We Can Close Mylan Deal in 2015

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) CFO Eyal Desheh remains upbeat about Teva’s attempts to buy Mylan N.V. (Nasdaq: MYL). At the same time, Mylan continues to oppose the takeover More…




You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Copyright © 2021 Jewish Business News